Prime Medicine (PRME) Leases (2021 - 2025)
Prime Medicine (PRME) has disclosed Leases for 5 consecutive years, with $126.2 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases rose 167.57% year-over-year to $126.2 million, compared with a TTM value of $126.2 million through Dec 2025, up 167.57%, and an annual FY2025 reading of $126.2 million, up 167.57% over the prior year.
- Leases was $126.2 million for Q4 2025 at Prime Medicine, up from $117.9 million in the prior quarter.
- Across five years, Leases topped out at $126.2 million in Q4 2025 and bottomed at $7.0 million in Q1 2025.
- Average Leases over 5 years is $47.6 million, with a median of $32.3 million recorded in 2022.
- The sharpest move saw Leases soared 238.25% in 2024, then tumbled 84.41% in 2025.
- Year by year, Leases stood at $10.7 million in 2021, then surged by 174.94% to $29.5 million in 2022, then tumbled by 52.81% to $13.9 million in 2023, then skyrocketed by 238.25% to $47.2 million in 2024, then skyrocketed by 167.57% to $126.2 million in 2025.
- Business Quant data shows Leases for PRME at $126.2 million in Q4 2025, $117.9 million in Q3 2025, and $120.2 million in Q2 2025.